2023-09-012024-08-312024-08-31false14323037THERAPY BEAU LTD2024-10-1486900iso4217:GBPxbrli:pure143230372023-09-01143230372024-08-31143230372023-09-012024-08-31143230372022-08-30143230372023-08-31143230372022-08-302023-08-3114323037bus:SmallEntities2023-09-012024-08-3114323037bus:AuditExempt-NoAccountantsReport2023-09-012024-08-3114323037bus:FullAccounts2023-09-012024-08-3114323037bus:PrivateLimitedCompanyLtd2023-09-012024-08-3114323037core:WithinOneYear2024-08-3114323037core:AfterOneYear2024-08-3114323037core:WithinOneYear2023-08-3114323037core:AfterOneYear2023-08-3114323037core:ShareCapital2024-08-3114323037core:SharePremium2024-08-3114323037core:RevaluationReserve2024-08-3114323037core:OtherReservesSubtotal2024-08-3114323037core:RetainedEarningsAccumulatedLosses2024-08-3114323037core:ShareCapital2023-08-3114323037core:SharePremium2023-08-3114323037core:RevaluationReserve2023-08-3114323037core:OtherReservesSubtotal2023-08-3114323037core:RetainedEarningsAccumulatedLosses2023-08-3114323037core:LandBuildings2024-08-3114323037core:PlantMachinery2024-08-3114323037core:Vehicles2024-08-3114323037core:FurnitureFittings2024-08-3114323037core:OfficeEquipment2024-08-3114323037core:NetGoodwill2024-08-3114323037core:IntangibleAssetsOtherThanGoodwill2024-08-3114323037core:ListedExchangeTraded2024-08-3114323037core:UnlistedNon-exchangeTraded2024-08-3114323037core:LandBuildings2023-08-3114323037core:PlantMachinery2023-08-3114323037core:Vehicles2023-08-3114323037core:FurnitureFittings2023-08-3114323037core:OfficeEquipment2023-08-3114323037core:NetGoodwill2023-08-3114323037core:IntangibleAssetsOtherThanGoodwill2023-08-3114323037core:ListedExchangeTraded2023-08-3114323037core:UnlistedNon-exchangeTraded2023-08-3114323037core:LandBuildings2023-09-012024-08-3114323037core:PlantMachinery2023-09-012024-08-3114323037core:Vehicles2023-09-012024-08-3114323037core:FurnitureFittings2023-09-012024-08-3114323037core:OfficeEquipment2023-09-012024-08-3114323037core:NetGoodwill2023-09-012024-08-3114323037core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3114323037core:ListedExchangeTraded2023-09-012024-08-3114323037core:UnlistedNon-exchangeTraded2023-09-012024-08-3114323037core:MoreThanFiveYears2023-09-012024-08-3114323037core:Non-currentFinancialInstruments2024-08-3114323037core:Non-currentFinancialInstruments2023-08-3114323037dpl:CostSales2023-09-012024-08-3114323037dpl:DistributionCosts2023-09-012024-08-3114323037core:LandBuildings2023-09-012024-08-3114323037core:PlantMachinery2023-09-012024-08-3114323037core:Vehicles2023-09-012024-08-3114323037core:FurnitureFittings2023-09-012024-08-3114323037core:OfficeEquipment2023-09-012024-08-3114323037dpl:AdministrativeExpenses2023-09-012024-08-3114323037core:NetGoodwill2023-09-012024-08-3114323037core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3114323037dpl:GroupUndertakings2023-09-012024-08-3114323037dpl:ParticipatingInterests2023-09-012024-08-3114323037dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3114323037core:ListedExchangeTraded2023-09-012024-08-3114323037dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3114323037core:UnlistedNon-exchangeTraded2023-09-012024-08-3114323037dpl:CostSales2022-08-302023-08-3114323037dpl:DistributionCosts2022-08-302023-08-3114323037core:LandBuildings2022-08-302023-08-3114323037core:PlantMachinery2022-08-302023-08-3114323037core:Vehicles2022-08-302023-08-3114323037core:FurnitureFittings2022-08-302023-08-3114323037core:OfficeEquipment2022-08-302023-08-3114323037dpl:AdministrativeExpenses2022-08-302023-08-3114323037core:NetGoodwill2022-08-302023-08-3114323037core:IntangibleAssetsOtherThanGoodwill2022-08-302023-08-3114323037dpl:GroupUndertakings2022-08-302023-08-3114323037dpl:ParticipatingInterests2022-08-302023-08-3114323037dpl:GroupUndertakingscore:ListedExchangeTraded2022-08-302023-08-3114323037core:ListedExchangeTraded2022-08-302023-08-3114323037dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-08-302023-08-3114323037core:UnlistedNon-exchangeTraded2022-08-302023-08-3114323037core:NetGoodwill2024-08-3114323037core:IntangibleAssetsOtherThanGoodwill2024-08-3114323037core:LandBuildings2024-08-3114323037core:PlantMachinery2024-08-3114323037core:Vehicles2024-08-3114323037core:FurnitureFittings2024-08-3114323037core:OfficeEquipment2024-08-3114323037core:AfterOneYear2024-08-3114323037core:WithinOneYear2024-08-3114323037core:ListedExchangeTraded2024-08-3114323037core:UnlistedNon-exchangeTraded2024-08-3114323037core:ShareCapital2024-08-3114323037core:SharePremium2024-08-3114323037core:RevaluationReserve2024-08-3114323037core:OtherReservesSubtotal2024-08-3114323037core:RetainedEarningsAccumulatedLosses2024-08-3114323037core:NetGoodwill2023-08-3114323037core:IntangibleAssetsOtherThanGoodwill2023-08-3114323037core:LandBuildings2023-08-3114323037core:PlantMachinery2023-08-3114323037core:Vehicles2023-08-3114323037core:FurnitureFittings2023-08-3114323037core:OfficeEquipment2023-08-3114323037core:AfterOneYear2023-08-3114323037core:WithinOneYear2023-08-3114323037core:ListedExchangeTraded2023-08-3114323037core:UnlistedNon-exchangeTraded2023-08-3114323037core:ShareCapital2023-08-3114323037core:SharePremium2023-08-3114323037core:RevaluationReserve2023-08-3114323037core:OtherReservesSubtotal2023-08-3114323037core:RetainedEarningsAccumulatedLosses2023-08-3114323037core:NetGoodwill2022-08-3014323037core:IntangibleAssetsOtherThanGoodwill2022-08-3014323037core:LandBuildings2022-08-3014323037core:PlantMachinery2022-08-3014323037core:Vehicles2022-08-3014323037core:FurnitureFittings2022-08-3014323037core:OfficeEquipment2022-08-3014323037core:AfterOneYear2022-08-3014323037core:WithinOneYear2022-08-3014323037core:ListedExchangeTraded2022-08-3014323037core:UnlistedNon-exchangeTraded2022-08-3014323037core:ShareCapital2022-08-3014323037core:SharePremium2022-08-3014323037core:RevaluationReserve2022-08-3014323037core:OtherReservesSubtotal2022-08-3014323037core:RetainedEarningsAccumulatedLosses2022-08-3014323037core:AfterOneYear2023-09-012024-08-3114323037core:WithinOneYear2023-09-012024-08-3114323037core:Non-currentFinancialInstrumentscore:CostValuation2023-09-012024-08-3114323037core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-012024-08-3114323037core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-012024-08-3114323037core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-012024-08-3114323037core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-012024-08-3114323037core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-012024-08-3114323037core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3114323037core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3114323037core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3114323037core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3114323037core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:CostValuation2023-08-3114323037core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-3114323037core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-3114323037core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-3114323037core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-3114323037core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-3114323037core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-3114323037core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-3114323037core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-3114323037bus:Director12023-09-012024-08-31

THERAPY BEAU LTD

Registered Number
14323037
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2024

THERAPY BEAU LTD
Company Information
for the year from 1 September 2023 to 31 August 2024

Director

ROBERTS, Beau-Jessica Ruth

Registered Address

2 Colchester Road
St. Osyth
Clacton-On-Sea
CO16 8HA

Registered Number

14323037 (England and Wales)
THERAPY BEAU LTD
Balance Sheet as at
31 August 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets35,6445,076
5,6445,076
Current assets
Debtors128-
Cash at bank and on hand24,22518,321
24,35318,321
Creditors amounts falling due within one year4(9,737)(7,397)
Net current assets (liabilities)14,61610,924
Total assets less current liabilities20,26016,000
Net assets20,26016,000
Capital and reserves
Profit and loss account20,26016,000
Shareholders' funds20,26016,000
The financial statements were approved and authorised for issue by the Director on 14 October 2024, and are signed on its behalf by:
ROBERTS, Beau-Jessica Ruth
Director
Registered Company No. 14323037
THERAPY BEAU LTD
Notes to the Financial Statements
for the year ended 31 August 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Office Equipment25
2.Average number of employees

20242023
Average number of employees during the year00
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 September 231,7005,0686,768
Additions2,2002492,449
At 31 August 243,9005,3179,217
Depreciation and impairment
At 01 September 234251,2671,692
Charge for year8691,0121,881
At 31 August 241,2942,2793,573
Net book value
At 31 August 242,6063,0385,644
At 31 August 231,2753,8015,076
4.Creditors: amounts due within one year

2024

2023

££
Taxation and social security9,7376,137
Other creditors-1,260
Total9,7377,397
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.